title: Induction of genital immunity by DNA priming and intranasal booster immunization with a replication-defective adenoviral recombinant.
abstract: Mice immunized through different routes such as i.m., intradermally, or intratracheally with a DNA vaccine to rabies virus developed high titers of serum Ab but only borderline levels of mucosal Abs determined from vaginal secretions. DNA vaccines given by either route enhanced vaginal IgA and IgG2a secretion upon a subsequent intranasal booster immunization with an E1-deleted adenoviral recombinant expressing the same Ag of rabies virus. DNA vaccine priming reduced the Ab response to the adenoviral Ags and counterbalanced the impaired B cell response to the rabies virus Ag expressed by the adenoviral recombinant in mice preimmune to adenovirus. The vaginal B cell response could further be enhanced by using the Th2-type cytokines IL-4 or IL-5 as genetic adjuvants concomitantly with the DNA vaccine before intranasal booster immunization with the recombinant vaccine.
authors.affiliation: Wistar Institute, Philadelphia, PA 19104, USA.
authors.forename: Z Q
authors.initials: ZQ
authors.lastname: Xiang
authors.forename: S
authors.initials: S
authors.lastname: Pasquini
authors.forename: H C
authors.initials: HC
authors.lastname: Ertl
mesh_terms: D000260:Adenoviruses, Human / Q000235:genetics / Q000276:immunology*; D000281:Administration, Intranasal; D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D000956:Antigens, Viral / Q000096:biosynthesis / Q000235:genetics; D003673:Defective Viruses / Q000235:genetics / Q000276:immunology*; D005260:Female; D005822:Genetic Vectors / Q000008:administration & dosage / Q000276:immunology; D018928:Immunity, Mucosal / Q000235:genetics / Q000276:immunology; D007117:Immunization, Secondary / Q000379:methods*; D007271:Injections, Intradermal; D007273:Injections, Intramuscular; D015847:Interleukin-4 / Q000008:administration & dosage; D015848:Interleukin-5 / Q000008:administration & dosage; D051379:Mice; D008809:Mice, Inbred C3H; D011819:Rabies Vaccines / Q000235:genetics / Q000276:immunology; D011995:Recombination, Genetic / Q000276:immunology*; D017778:Vaccines, Combined / Q000235:genetics / Q000276:immunology; D019444:Vaccines, DNA / Q000276:immunology*; D014621:Vagina / Q000276:immunology*; D014765:Viral Vaccines / Q000235:genetics / Q000276:immunology; D014779:Virus Replication / Q000235:genetics / Q000276:immunology
chemical_list: D000914:Antibodies, Viral; D000956:Antigens, Viral; D015848:Interleukin-5; D011819:Rabies Vaccines; D017778:Vaccines, Combined; D019444:Vaccines, DNA; D014765:Viral Vaccines; D015847:Interleukin-4